En Es
Categories

Industry News

Ortho Clinical Diagnostics presenta avances cardíacos en EuroMedLab 2019

By Labmedica en español staff writers
28 May 2019

Imagen: Láminas de productos de química VITROS de pruebas múltiples (Fotografía cortesía de Ortho Clinical Diagnostics).Ortho Clinical Diagnostics (Raritan, NJ, EUA) patrocinó un taller educativo sobre los ensayos de troponina de alta sensibilidad y presentó cinco pósteres científicos en EuroMedLab 2019, durante el 23º Congreso Europeo de Química Clínica y Medicina de Laboratorio IFCC-EFLM, que se realizó del 19 al 23 de mayo de 2019 en el CCIB -Centro de Convenciones Internacional de Barcelona. Ortho también mostró sus nuevas láminas de productos químicos VITROS, la Celda VITROS, una solución de automatización compacta que permite que dos instrumentos VITROS XT 7600 (lanzados en 2018) funcionen como una solución perfecta, y el Sistema Integrado VITROS XT 7600 en su stand durante el Congreso.

Ortho, una empresa de diagnóstico in vitro que atiende a las comunidades de inmunohematología y laboratorio clínico, ofrece sofisticadas tecnologías de análisis, automatización, gestión de la información y herramientas de interpretación a los laboratorios clínicos de todo el mundo para ayudarlos a funcionar de manera más eficiente y eficaz y mejorar la atención al paciente. Los productos y servicios de alta calidad de Ortho permiten a los profesionales de la salud tomar decisiones de tratamiento mejor informadas en hospitales, redes de hospitales, bancos de sangre y laboratorios en más de 125 países y territorios.

Además del taller educativo, “Uso clínico y desempeño de los ensayos de troponina de alta sensibilidad con el algoritmo Esc 0-1: Superando los desafíos en la implementación”, Ortho presentó los siguientes cinco pósteres científicos en EuroMedLab:

? Evaluación de las nuevas láminas de productos de química VITROS de prueba múltiple en el sistema integrado VITROS XT 7600.
? Sigmamétrica para evaluar la calidad analítica de las nuevas láminas de productos de química VITROS XT de prueba múltiple.
? La precisión de las nuevas láminas de productos de química VITROS de prueba múltiple en el sistema integrado VITROS XT 7600.
? Evaluación del desempeño del ensayo VITROS hs Troponin I en los sistemas VITROS ECi/ECiQ y 3600 Immunodiagnostic y VITROS 5600/XT 7600.
? Evaluación del desempeño de los productos de inmunodiagnóstico VITROS B • R • A • H • M • S Ensayo PCT sobre el sistema inmunodiagnóstico VITROS 3600.

“Ortho está comprometido a mantenerse a la vanguardia del entorno de laboratorio clínico en rápida evolución”, dijo Joan Martin, vicepresidente ejecutivo y jefe de la región EMEA de Ortho. “En el EuroMedLab de este año, estamos orgullosos de presentar datos sobre dos de nuestras ofertas de productos clave: nuestro nuevo análisis de troponina de alta sensibilidad y el VITROS XT MicroSlide de Ortho. El XT MicroSlide puede realizar dos pruebas simultáneamente para mejorar el desempeño del flujo de trabajo del laboratorio, la productividad y los resultados clínicos”.

Enlace relacionado:
Ortho Clinical Diagnostics



E-mail Print
FaceBook Twitter Google+ Linked in

ORTHO CLINICAL DIAGNOSTICS

Ortho Clinical Diagnostics is a global provider of in vitro diagnostics, including testing platforms and clinical assay tests to monitor disease progression across multiple disease categories such as infectious diseases, cardiology and endocrinology. It also offers laboratory systems and blood typing products in immunohematology to hospitals, hospital networks, blood banks, and labs around the world.
More info

More articles about ORTHO CLINICAL DIAGNOSTICS

20 May 2019
Ortho Clinical Diagnostics Presents Cardiac Advances at EuroMedLab 2019
Ortho Clinical Diagnostics sponsored an educational workshop on high-sensitivity troponin assays and presented five scientific posters at EuroMedLab 2019, the 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, which took place from May 19-23, 2019, at the CCIB - Centre Convencions Internacional in Barcelona.
Read More
17 Oct 2017
Ortho Clinical Diagnostics and EKF Diagnostics Collaborate for Assay
Ortho Clinical Diagnostics and EKF Diagnostics have entered into an agreement that allows Ortho customers to access the Beta-Hydroxybutyrate (BHB) assay, an important marker used in conjunction with clinical findings and other lab tests for the diagnosis and management of ketoacidosis and its main causative factor, diabetic ketoacidosis (DKA). The fully automated assay is now available for use on Ortho's VITROS 4600 chemistry system and the VITROS 5600 integrated system.
Read More

Additional news

21 Apr 2021
FDA Clears First-Ever AI Mammography Triage Software that Supports both 3D and 2D Mammography
The US Food and Drug Administration has cleared the first-ever artificial intelligence (AI) mammography triage software that supports both 3D and 2D mammography.
Read More
20 Apr 2021
Global Digital PCR and Real-Time PCR Market Growth Driven by Increasing Cases of Infectious Diseases
Increasing cases of infectious diseases, rising geriatric population and growing number of genetic disorders will propel the growth of the global digital PCR and real-time PCR market over the next decade. Additionally, PCR advances, fulfillment of the human genome project, and expanding R&D will increase the utilization of biomarker profiling for sickness diagnostics, thus further driving market growth.
Read More
19 Apr 2021
Siemens Completes Acquisition of Varian to Create Integrated Portfolio of Imaging, Laboratory Diagnostics, AI and Cancer Treatment
Siemens Healthineers (Erlangen, Germany) has successfully completed the acquisition of Varian Medical Systems, Inc. (Palo Alto, CA, USA), thus strengthening its position as a holistic partner in healthcare.
Read More
16 Apr 2021
Eppendorf Introduces Multipurpose Centrifuge 5910 Ri to Accelerate Results
Eppendorf AG (Hamburg, Germany) has introduced a new centrifuge designed to increase efficiency in the laboratory, Centrifuge 5910 Ri, a successor to the company’s popular Centrifuge 5910 R.
Read More
16 Apr 2021
Artificial Intelligence (AI) in Medical Diagnostics Market to Reach USD 3.86 Billion by 2025
The global Artificial Intelligence (AI) in Medical Diagnostics Market is projected to grow at a CAGR of 50.2% from USD 0.5 billion in 2020 to USD 3.86 billion by 2025, driven primarily by government initiatives to increase the adoption of AI-based technologies, increasing demand for AI tools in the medical field, growing focus on reducing the workload of radiologists, influx of large and complex datasets, growth in funding for AI-based start-ups, and growing number of cross-industry partnerships and collaborations.
Read More
15 Apr 2021
Microsoft Acquires Radiology Vendor Nuance to Deliver New Cloud and AI Capabilities Across Healthcare
Microsoft Corporation (Redmond, WA, USA) will acquire Nuance Communications, Inc. (Burlington, MA, USA) in an all-cash transaction valued at USD 19.7 billion to combine their solutions and expertise that will deliver new cloud and AI capabilities across healthcare and other industries.
Read More
14 Apr 2021
Zoll Medical Acquires CSA Systems Manufacturer Respicardia
 ZOLL Medical Corporation (Chelmsford, MA, USA), an Asahi Kasei company, has acquired Respicardia, Inc. (Minnetonka, MN, USA), a provider of novel implantable neurostimulators for the treatment of moderate to severe Central Sleep Apnea (CSA).
Read More
13 Apr 2021
DiaSorin to Acquire Luminex to Broaden Positioning in Molecular Diagnostics Space
DiaSorin S.p.A. (?Saluggia?, Italy) has announced that its Board of Directors has unanimously approved and signed a definitive merger agreement for DiaSorin to acquire Luminex Corporation (Austin, TX, USA) for approximately USD 1.8 billion.
Read More
13 Apr 2021
Philips Collaborates with AI Startup Ibex to Accelerate Adoption of AI-Powered Digital Pathology Solutions
Royal Philips (Amsterdam, The Netherlands) and Ibex Medical Analytics (Tel Aviv, Israel) have entered into a strategic collaboration to jointly promote their digital pathology and AI solutions to hospitals, health networks and pathology labs worldwide.
Read More
Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions